The mediation MR analysis yielded the following results: when Bifidobacterium kashiwanohense served as a protective factor against CRC, CD40 on monocytes (2.82%) and CD45 on CD33+HLA-DR+CD14- (12.87%) mediated its genetic predictive effect on CRC risk. The gene discussed is PTPRC; the disease is colorectal carcinoma.